Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
In a recent study, 12-month progression-free survival was 67 percent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
In a recent study, 12-month progression-free survival was 67 percent
Only registered members have full access to PracticeUpdate content.